ERCC2 and cervical carcinoma: To address this gap, we performed a comprehensive literature review incorporating multiple relevant clinical studies and applied meta-analysis methods to systematically evaluate the correlations between ERCC2 Lys751Gln, Asp312Asn, and Arg156Arg SNP and the risk of cervical cancer, endometrial cancer, and ovarian cancer.